CYANOTCMedicinal Chemicals & Botanical ProductsFiscal year ends March 31

CYANOTECH CORP

Financials through Q2 FY2026, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 10, 2025

$0.70+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $5.11M
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Sep 30, 2025

Total debt

$8.36M

$7.36M due within a year

Net debt

$7.71M

After $649.00K of cash

Implied interest rate

9.62%

FY2025 interest ÷ average debt

Interest coverage

-3.7×

FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Cyanotech's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Cyanotech's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-4 reverse split on Nov 6, 2006
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CYAN.

Revenue growth8.5% · median 9.7%

Gross margin32.0% · median 61.1%

Operating margin-4.2% · median -26.4%

Net margin-7.0% · median -14.5%

Company	Revenue	Growth
NAII	$142.52M	+9.7%
SNYRQ	$27.70M	-17.5%
CYAN	$25.27M	+8.5%
HYEX	$6.29M	+84.1%
BON	–	–
LEEEF	–	–

Company

Exchange: OTC
Industry: Medicinal Chemicals & Botanical Products
Fiscal year ends: March 31
Employees: 83
Auditor: BPM LLP
SEC CIK: 768408

Advertisement
300 × 250